酪氨酸激酶抑制剂相关治疗药物监测的研究进展(11)
[73] BENCE AK,ANDERSON EB,HALEPOTA MA,et al. Phase Ⅰ pharmacokinetic studies evaluating single and multiple doses of oral GW572016,a dual EGFR-ErbB2 inhibitor,in healthy subjects[J]. Invest New Drugs ......
您现在查看是摘要页,全文长 1728 字符。